Treatment outcome of AT-B88 regimen for B-cell non-Hodgkin's lymphoma and surface immunoglobulin-positive acute lymphoblastic leukemia in children.

MLA

Horibe, K., et al. “Treatment Outcome of AT-B88 Regimen for B-Cell Non-Hodgkin’s Lymphoma and Surface Immunoglobulin-Positive Acute Lymphoblastic Leukemia in Children.” International Journal of Hematology, vol. 66, no. 1, July 1997, pp. 89–98. EBSCOhost, https://doi.org/10.1016/s0925-5710(97)00579-3.

APA

Horibe, K., Akiyama, Y., Kobayashi, M., Ishii, E., Matsuyama, T., Matsuzaki, A., Minegishi, M., & Ueda, K. (1997). Treatment outcome of AT-B88 regimen for B-cell non-Hodgkin’s lymphoma and surface immunoglobulin-positive acute lymphoblastic leukemia in children. International Journal of Hematology, 66(1), 89–98. https://doi.org/10.1016/s0925-5710(97)00579-3

Chicago

Horibe, K, Y Akiyama, M Kobayashi, E Ishii, T Matsuyama, A Matsuzaki, M Minegishi, and K Ueda. 1997. “Treatment Outcome of AT-B88 Regimen for B-Cell Non-Hodgkin’s Lymphoma and Surface Immunoglobulin-Positive Acute Lymphoblastic Leukemia in Children.” International Journal of Hematology 66 (1): 89–98. doi:10.1016/s0925-5710(97)00579-3.